ArticleCardiovascular toxicology2026
Exposure to Polystyrene Nanoplastics Induces Ferroptosis-Associated Cardiac Injury: Cell-Based Evidence for Lysosome-Associated NLRX1 Loss and an NLRX1-STING-NCOA4 Response.
Article in Cardiovascular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Nanoplastics are widespread environmental contaminants encountered through ingestion and inhalation, raising concerns about their cardiovascular toxicity. How polystyrene nanoplastics (PS-NPs) disrupt cardiomyocyte iron homeostasis remains unclear. We hypothesized that reduced NLR family member X1 (NLRX1) links PS-NP exposure to stimulator of interferon genes (STING) signaling and nuclear receptor coactivator 4 (NCOA4)-associated iron dysregulation. We examined primary neonatal mouse ventricular cardiomyocytes and an 8-week oral-exposure mouse model. In both models, PS-NPs reduced NLRX1 and glutathione peroxidase 4 (GPX4) protein levels, increased STING phosphorylation and acyl-CoA synthetase long-chain family member 4 (ACSL4) expression, and promoted iron accumulation and lipid peroxidation. Cell viability declined, and mice developed cardiac dysfunction and fibrosis. In cardiomyocytes, NLRX1 mRNA remained unchanged. Bafilomycin A1 attenuated NLRX1 protein loss, while NLRX1 showed greater spatial association with lysosome-associated membrane protein 1 (LAMP1)-positive compartments. NLRX1 overexpression reduced STING phosphorylation, iron accumulation, and lipid peroxidation. STING silencing decreased NCOA4 and increased ferritin heavy chain 1, whereas NCOA4 silencing attenuated GPX4 downregulation and ACSL4 upregulation. Re-expression experiments supported the functional ordering of NLRX1, STING, and NCOA4. Ferrostatin-1 (Fer-1) co-treatment attenuated iron accumulation, lipid peroxidation, and GPX4/ACSL4 changes in both models. It improved cardiomyocyte viability and attenuated cardiac dysfunction and fibrosis, although the myocardial phosphorylated-to-total STING ratio remained above control levels. These findings support ferroptosis-associated cardiac injury following PS-NP exposure, with cellular evidence implicating lysosome-associated NLRX1 protein loss and a downstream STING-NCOA4 response.
Indexed as
Identifiers
42762285What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.